Meta-analysis of lower perioperative blood glucose target levels for reduction of surgical-site infection.
- de Vries FE Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands.
- Gans SL Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands.
- Solomkin JS Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Allegranzi B Infection Prevention and Control Global Unit, Service Delivery and Safety, World Health Organization, Geneva, Switzerland.
- Egger M Institute of Social and Preventive Medicine, University of Berne, Berne, Berne, Switzerland.
- Dellinger EP Department of Surgery, University of Washington, Seattle, Washington, USA.
- Boermeester MA Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands.
- 2016-12-01
Published in:
- The British journal of surgery. - 2017
Blood Glucose
Clinical Protocols
Humans
Hyperglycemia
Hypoglycemia
Hypoglycemic Agents
Perioperative Care
Surgical Wound Infection
English
BACKGROUND
There is a clear association between hyperglycaemia and surgical-site infection (SSI). Intensive glucose control may involve a risk of hypoglycaemia, which in turn results in potentially severe complications. A systematic review was undertaken of studies comparing intensive versus conventional glucose control protocols in relation to reduction of SSI and other outcomes, including hypoglycaemia, mortality and stroke.
METHODS
PubMed, Embase, CENTRAL, CINAHL and WHO databases from 1 January 1990 to 1 August 2015 were searched. Inclusion criteria were RCTs comparing intensive with conventional glucose control protocols, and reporting on the incidence of SSI. Meta-analyses were performed with a random-effects model, and meta-regression was subsequently undertaken. Targeted blood glucose levels, achieved blood glucose levels, and important adverse events were summarized.
RESULTS
Fifteen RCTs were included. The summary estimate showed a significant benefit for an intensive compared with a conventional glucose control protocol in reducing SSI (odds ratio (OR) 0·43, 95 per cent c.i. 0·29 to 0·64; P < 0·001). A significantly higher risk of hypoglycaemic events was found for the intensive group compared with the conventional group (OR 5·55, 2·58 to 11·96), with no increased risk of death (OR 0·74, 0·45 to 1·23) or stroke (OR 1·37, 0·26 to 7·20). These results were consistent both in patients with and those without diabetes, and in studies with moderately strict and very strict glucose control.
CONCLUSION
Stricter and lower blood glucose target levels of less than 150 mg/dl (8·3 mmol/l), using an intensive protocol in the perioperative period, reduce SSI with an inherent risk of hypoglycaemic events but without a significant increase in serious adverse events.
There is a clear association between hyperglycaemia and surgical-site infection (SSI). Intensive glucose control may involve a risk of hypoglycaemia, which in turn results in potentially severe complications. A systematic review was undertaken of studies comparing intensive versus conventional glucose control protocols in relation to reduction of SSI and other outcomes, including hypoglycaemia, mortality and stroke.
METHODS
PubMed, Embase, CENTRAL, CINAHL and WHO databases from 1 January 1990 to 1 August 2015 were searched. Inclusion criteria were RCTs comparing intensive with conventional glucose control protocols, and reporting on the incidence of SSI. Meta-analyses were performed with a random-effects model, and meta-regression was subsequently undertaken. Targeted blood glucose levels, achieved blood glucose levels, and important adverse events were summarized.
RESULTS
Fifteen RCTs were included. The summary estimate showed a significant benefit for an intensive compared with a conventional glucose control protocol in reducing SSI (odds ratio (OR) 0·43, 95 per cent c.i. 0·29 to 0·64; P < 0·001). A significantly higher risk of hypoglycaemic events was found for the intensive group compared with the conventional group (OR 5·55, 2·58 to 11·96), with no increased risk of death (OR 0·74, 0·45 to 1·23) or stroke (OR 1·37, 0·26 to 7·20). These results were consistent both in patients with and those without diabetes, and in studies with moderately strict and very strict glucose control.
CONCLUSION
Stricter and lower blood glucose target levels of less than 150 mg/dl (8·3 mmol/l), using an intensive protocol in the perioperative period, reduce SSI with an inherent risk of hypoglycaemic events but without a significant increase in serious adverse events.
- Language
-
- English
- Open access status
- green
- Identifiers
-
- DOI 10.1002/bjs.10424
- PMID 27901264
- Persistent URL
- https://sonar.ch/global/documents/33521
Statistics
Document views: 21
File downloads:
- fulltext.pdf: 0